From: The relationship between myasthenia gravis and COVID-19: a systematic review
No. | Major components | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Were patient’s demographic characteristics clearly described? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
2 | Was the patient’s history clearly described and presented as a timeline? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
3 | Was the current clinical condition of the patient on presentation clearly described? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
4 | Were diagnostic tests or assessment methods and the results clearly described? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
5 | Was the intervention(s) or treatment procedure(s) clearly described? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
6 | Was the post-intervention clinical condition clearly described? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
7 | Were adverse events (harms) or unanticipated events identified and described? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
8 | Does the case report provide takeaway lessons? | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y |
 | Overall appraisal | I | I | I | I | I | I | I | I | I | I |